Clinical evaluation of miradon.
作者信息
KELLAWAY G
出版信息
Br Med J. 1958 Oct 11;2(5101):889-91. doi: 10.1136/bmj.2.5101.889.
Abstract
摘要
相似文献
1
Clinical evaluation of miradon.
Br Med J. 1958 Oct 11;2(5101):889-91. doi: 10.1136/bmj.2.5101.889.
2
OUTPATIENT ANTICOAGULATION: A PROBLEM IN LONG-TERM MANAGEMENT.
Va Med Mon (1918). 1964 Apr;91:149-54.
3
Evaluation of anticoagulant therapy with anisindione (miradon).
Can Med Assoc J. 1959 May 15;80(10):785-90.
4
ATTEMPTED REDUCTION OF ADHESIVE PLATELETS AFTER CARDIAC INFARCTION.
Lancet. 1964 Sep 12;2(7359):541-3. doi: 10.1016/s0140-6736(64)90614-2.
5
[Evaluation and treatment of disorders of the coronary circulation].
Dtsch Med J. 1952 Sep 9;3(17-18):390-7.
6
Agranulocytosis during phenindione therapy.
Br Med J. 1957 May 11;1(5027):1102-3. doi: 10.1136/bmj.1.5027.1102-a.
7
Coronary occlusion and myocardial infarction.
R I Med J. 1953 May;36(5):251-2.
8
AN ASSESSMENT OF LONG-TERM ANTICOAGULANT ADMINISTRATION AFTER CARDIAC INFARCTION. SECOND REPORT OF THE WORKING PARTY ON ANTICOAGULANT THERAPY IN CORONARY THROMBOSIS TO THE MEDICAL RESEARCH COUNCIL.
Br Med J. 1964 Oct 3;2(5413):837-43. doi: 10.1136/bmj.2.5413.837.
9
Clinical experience experience with the anticoagulant anisindione (miradon).
Surg Gynecol Obstet. 1959 May;108(5):605-15.
10
CURRENT MYTHS AND REALITIES IN ANTICOAGULANT THERAPY FOR CORONARY HEART DISEASE.
Med Clin North Am. 1964 Mar;48:355-70.
引用本文的文献
1
Pharmacokinetics of 2-phenyl-1,3-indandione in the rat after i.v. and oral administration.
Eur J Drug Metab Pharmacokinet. 1979;4(4):225-9. doi: 10.1007/BF03189431.
本文引用的文献
1
Preliminary report on the clinical use of a new anticoagulant, phenylindandione.
Circulation. 1950 May;1(5):1195-1204. doi: 10.1161/01.cir.1.5.1195.
2
A new prothrombopenic drug, phenylindanedione.
Can Med Assoc J. 1950 May;62(5):465-70.
3
Tromexan in the treatment of coronary thrombosis.
Am Heart J. 1951 Dec;42(6):864-75. doi: 10.1016/0002-8703(51)90058-0.
4
Tromexan-3,3'-carboxymethylenebis (4-hydroxycoumarin) ethyl ester; experimental and clinical properties.
Circulation. 1951 Feb;3(2):164-70. doi: 10.1161/01.cir.3.2.164.
5
Studies on the anticoagulant phenindione. II. Details regarding its administration in two hundred cases.
Am Heart J. 1957 Jan;53(1):132-44. doi: 10.1016/0002-8703(57)90389-7.
6
An evaluation of a new anticoagulant, acenocoumarin (sintrom).
Circulation. 1956 Mar;13(3):400-3. doi: 10.1161/01.cir.13.3.400.
7
Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.
Circulation. 1954 Nov;10(5):680-4. doi: 10.1161/01.cir.10.5.680.
8
Clinical experience with coumarin anticoagulants warfarin and warfarin sodium.
AMA Arch Intern Med. 1954 Aug;94(2):213-20. doi: 10.1001/archinte.1954.00250020047003.
9
Therapeutic evaluation of a new anticoagulant, phenylindandione.
Ann Surg. 1953 Sep;138(3):467-75. doi: 10.1097/00000658-195309000-00019.
10
Clinical evaluation of ethyl biscoumacetate (tromexan).
Am J Med. 1953 Jun;14(6):694-703. doi: 10.1016/0002-9343(53)90388-x.
Zotero 插件